samedan logo

home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Simon Caplan

Will Brown

We're also on Twitter! Follow us @PMPSmag   


Click here to view the digital version of PMPS




Click here to view the digital version



Featured in this issue
COVID-19: Packaging and Protection Supplement
COVID-19: Packaging and Protection Supplement

Replacing Paper with Productivity: Assuring Quality in Vaccine Manufacturing

Paperless systems are the future, but they don’t come without their concerns. Acceptance of paperless solutions must also ensure quality control at every stage.
COVID-19: Packaging and Protection Supplement
COVID-19: Packaging and Protection Supplement

PMPS and FlyPharma Webinar: What We Learned

Industry experts reveal their experience of our maiden webinar, discuss how COVID-19 has impacted their sectors, and tell us what challenges are yet to come.
  COVID-19: Packaging and Protection Supplement
COVID-19: Packaging and Protection Supplement

Pandemic Poses Cold Chain Challenges

Packaging, moving, distributing, and delivering millions of subzero vaccines around the world intensifies the need for well-prepared temperature controlled logistics that can create an unbroken cold chain.


Published quarterly in
February, May,
August, and November


News and Press Releases

New Controlled-Rate Freezers Provide Optimal Sample Protection and Support GMP and 21 CFR Part 11 Requirements

Waltham, Mass. – (January 11, 2021) – In line with the need for pharmaceutical research, cell and gene therapy, vaccine production and biobanking laboratories for dependable sample protection, the new series of controlled-rate freezers from Thermo Fisher Scientific provides precise, repeatable freezing capabilities, while enhancing data traceability to support GMP and 21 CFR part 11 requirements.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement